171 related articles for article (PubMed ID: 2200731)
1. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.
Karjalainen JK
Diabetes; 1990 Sep; 39(9):1144-50. PubMed ID: 2200731
[TBL] [Abstract][Full Text] [Related]
2. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
Knip M; Karjalainen J; Akerblom HK
Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
[TBL] [Abstract][Full Text] [Related]
3. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.
Bingley PJ; Christie MR; Bonifacio E; Bonfanti R; Shattock M; Fonte MT; Bottazzo GF; Gale EA
Diabetes; 1994 Nov; 43(11):1304-10. PubMed ID: 7926304
[TBL] [Abstract][Full Text] [Related]
4. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.
Bonifacio E; Bingley PJ; Shattock M; Dean BM; Dunger D; Gale EA; Bottazzo GF
Lancet; 1990 Jan; 335(8682):147-9. PubMed ID: 1967440
[TBL] [Abstract][Full Text] [Related]
5. Immunogenetic determinants and prediction of IDDM in French schoolchildren.
Lévy-Marchal C; Dubois F; Noël M; Tichet J; Czernichow P
Diabetes; 1995 Sep; 44(9):1029-32. PubMed ID: 7657024
[TBL] [Abstract][Full Text] [Related]
6. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
Williams AJ; Bingley PJ; Moore WP; Gale EA;
Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
[TBL] [Abstract][Full Text] [Related]
7. Glutamic acid decarboxylase and islet cell antibodies in healthy Estonian children.
Adojaan B; Sabbah E; Vähäsalo P; Akerblom HK; Podar T; Knip M
J Pediatr Endocrinol Metab; 1999; 12(5):667-72. PubMed ID: 10703539
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
Kretowski A; Szelachowska M; Kinalska I
Pol Arch Med Wewn; 1999 Apr; 101(4):323-7. PubMed ID: 10740410
[TBL] [Abstract][Full Text] [Related]
9. Islet cell autoimmunity and progression to insulin-dependent diabetes mellitus in genetically high- and low-risk siblings of diabetic children. The Childhood Diabetes in Finland (DiMe) Study Group.
Karjalainen J; Vähasalo P; Knip M; Tuomilehto-Wolf E; Virtala E; Akerblom HK
Eur J Clin Invest; 1996 Aug; 26(8):640-9. PubMed ID: 8872058
[TBL] [Abstract][Full Text] [Related]
10. Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM.
Brown FM; Kamalesh M; Adri MN; Rabinowe SL
Diabetes Care; 1988 Jan; 11(1):30-3. PubMed ID: 3276475
[TBL] [Abstract][Full Text] [Related]
11. Serial changes in the prevalence of islet cell antibodies and islet cell antibody titer in children with IDDM of abrupt or slow onset.
Urakami T; Miyamoto Y; Matsunaga H; Owada M; Kitagawa T
Diabetes Care; 1995 Aug; 18(8):1095-9. PubMed ID: 7587843
[TBL] [Abstract][Full Text] [Related]
12. High genetic risk for IDDM in the Pacific Northwest. First report from the Washington State Diabetes Prediction Study.
Rowe RE; Leech NJ; Nepom GT; McCulloch DK
Diabetes; 1994 Jan; 43(1):87-94. PubMed ID: 8262322
[TBL] [Abstract][Full Text] [Related]
13. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM.
Karjalainen J; Knip M; Mustonen A; Ilonen J; Akerblom HK
Diabetes; 1986 May; 35(5):620-2. PubMed ID: 3514336
[TBL] [Abstract][Full Text] [Related]
14. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM.
Samuelsson U; Ludvigsson J; Sundkvist G
Diabetes Res Clin Pract; 1994 Dec; 26(3):155-62. PubMed ID: 7736895
[TBL] [Abstract][Full Text] [Related]
15. Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM.
Rabinowe SL; Brown FM; Watts M; Kadrofske MM; Vinik AI
Diabetes Care; 1989 Jan; 12(1):1-6. PubMed ID: 2653745
[TBL] [Abstract][Full Text] [Related]
16. Increased frequency of islet cell antibodies in unaffected brothers of children with type 1 diabetes.
Eskola V; Vähäsalo P; Akerblom HK; Knip M;
Horm Res; 2003; 59(4):195-200. PubMed ID: 12649574
[TBL] [Abstract][Full Text] [Related]
17. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
Gardner SG; Gale EA; Williams AJ; Gillespie KM; Lawrence KE; Bottazzo GF; Bingley PJ
Diabetes Care; 1999 Dec; 22(12):2049-54. PubMed ID: 10587841
[TBL] [Abstract][Full Text] [Related]
18. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
Mustonen A; Knip M; Akerblom HK
Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
[TBL] [Abstract][Full Text] [Related]
19. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
[TBL] [Abstract][Full Text] [Related]
20. Progression to type I diabetes in autoimmune endocrine patients with islet cell antibodies.
Bosi E; Becker F; Bonifacio E; Wagner R; Collins P; Gale EA; Bottazzo GF
Diabetes; 1991 Aug; 40(8):977-84. PubMed ID: 1860562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
